Skip to main content
. Author manuscript; available in PMC: 2019 Dec 30.
Published in final edited form as: Eur J Cancer. 2011 Jan 7;47(4):640–648. doi: 10.1016/j.ejca.2010.11.019

Fig. 1 –

Fig. 1 –

In vitro irinotecan accumulation in control and ABCG2-expressing cells. Cells were loaded with 2 μM irinotecan in DMEM medium (without FBS) for 60 min at 37 °C in the absence or presence of either 5 μFM GF120418, 5 μM MBLI-87 or 10 μM fumitremorgin C. Intracellular irinotecan accumulation was quantified by HPLC MS/MS. Results were expressed as ng irinotecan/mg protein.